Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 230-232

  Re, Maria Carla ^a   Furlini, Giuliano ^a   Vignoli, Monica ^a   Ramazzotti, Eric ^a   Zauli, Giorgio ^b   Placa, Michele L A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0029963310     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.230-232.1996     Document Type: Article

References (13)

1. Arya, S. H., and R. C. Gallo. 1986. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:2209-2213.
2. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368.
3. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Evidence that basic fibroblast growth factor and HIV type-1 Tat protein synergize in inducing Kaposi's sarcoma development. Nature (London) 371:674-680.
4. Franchini, G., M. Robert-Guroff, A. Aldovini, N. C. Kan, and F. Wong-Staal. 1987. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood 2:437-441.
5. Krone, W. J. A., C. Debouck, L. G. Epstein, P. Heutink, R. Meloen, and J. Goudsmit. 1988. Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. J. Med. Virol. 26:261-270.
6. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
7. Morfini, M., D. Rafanelli, E. Filimberti, S. Cinotti, R. Piazza, C. Longo, and P. Rossi Ferrini. 1989. Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates. Thromb. Res. 56:169-178.
8. Peerlinck, K., P. Goubau, G. Coppens, J. Desmyter, and J. Vermylen. 1994. Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity? Vox Sang. 67(Suppl. 1):14-16.
9. Re, M. C., G. Furlini, M. Vignoli, E. Ramazzotti, G. Roderigo, V. De Rosa, G. Zauli, S. Lolli, S. Capitani, and M. La Placa. 1995. Effect of antibody to human immunodeficiency virus type-1 (HIV-1) Tat protein on the viral replication in vitro and progression of HIV-1 disease in vivo. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 10:608-616.
10. Reiss, P., J. P. A. Lange, A. De Ronde, F. De Wolf, J. Dekker, C. Debouc, and J. Goudsmit. 1990. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. J. Med. Virol. 30:163-168.
11. Reiss, P., F. De Wolf, C. L. Kuiken, A. De Ronde, J. Dekker, C. A. B. Boucher, J. P. A. Lange, C. Debouck, J. M. A. Lange, and J. Goudsmit. 1991. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, lev, tat and protease in predicting development of AIDS in HIV-1-infected individuals. J. Acquired Immune Defic. Syndr. 4:165-172.
12. Steinaa, L., A. M. Sorensen, J. O. Nielsen, and J. E. S. Hansen. 1994. Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139:263-271.
13. Zauli, G., M. La Placa, M. Vignoli, M. C. Re, D. Gibellini, G. Furlini, D. Milani, M. Marchisio, M. Mazzoni, and S. Capitani. 1995. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1-LTR transactivating activity. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 10:306-316.